Tarka - 0074-3289-13 - (Trandolapril and Verapamil Hydrochloride)

Alphabetical Index


Drug Information of Tarka

Product NDC: 0074-3289
Proprietary Name: Tarka
Non Proprietary Name: Trandolapril and Verapamil Hydrochloride
Active Ingredient(s): 2; 240    mg/1; mg/1 & nbsp;   Trandolapril and Verapamil Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Tarka

Product NDC: 0074-3289
Labeler Name: AbbVie Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020591
Marketing Category: NDA
Start Marketing Date: 19961022

Package Information of Tarka

Package NDC: 0074-3289-13
Package Description: 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0074-3289-13)

NDC Information of Tarka

NDC Code 0074-3289-13
Proprietary Name Tarka
Package Description 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0074-3289-13)
Product NDC 0074-3289
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Trandolapril and Verapamil Hydrochloride
Dosage Form Name TABLET, FILM COATED, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 19961022
Marketing Category Name NDA
Labeler Name AbbVie Inc.
Substance Name TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
Strength Number 2; 240
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC]

Complete Information of Tarka


General Information